Search Results
You are looking at 1 - 10 of 22 items for
- Author: S. Davies x
- Refine by access: All content x
Search for other papers by Y. S. Davidson in
Google Scholar
PubMed
Search for other papers by I. Davies in
Google Scholar
PubMed
Search for other papers by C. Goddard in
Google Scholar
PubMed
ABSTRACT
The mechanism of water conservation is impaired in ageing mammals. An age-related defect in the release of vasopressin has been implicated but, more recently, attention has moved to the renal component of the water conservation mechanism. Previous studies using renal cells prepared from mice of different ages have shown that the threshold dose of vasopressin required to elicit a significant rise in cyclic AMP (cAMP) was greater in older animals. The dose–response curve was moved to the right in 35-month-old mice, i.e. the concentration of vasopressin required to give maximum cAMP output was increased. To investigate this further we examined the binding of vasopressin to renal medullary cells maintained in short-term culture, to determine whether the decreased response of cAMP levels to vasopressin is due to changes in hormone-receptor interaction. In 6-month-old male mice the dissociation constant (K d) was 2·38 nmol/l and the maximum binding of the hormone (Bmax) was 47·6 fmol/106 cells, and at 30 months of age K d was 2·37 nmol/l and Bmax was 47·0 fmol/106 cells. In female mice the changes were more complicated because the data for the 6-month-old mice could be split into two groups. It is concluded that there are no age-related differences in the numbers of receptors or their affinity for vasopressin, and that the decreased cAMP response is probably associated with post-receptor mechanisms in this species.
J. Endocr. (1987) 115, 379–385
Search for other papers by C. A. Ollis in
Google Scholar
PubMed
Search for other papers by R. Davies in
Google Scholar
PubMed
Search for other papers by D. S. Munro in
Google Scholar
PubMed
Search for other papers by S. Tomlinson in
Google Scholar
PubMed
ABSTRACT
Subconfluent human thyroid cells in monolayer, isolated from thyrotoxic tissue or non-toxic goitres obtained at surgery, responded to the addition of epidermal growth factor (EGF) with an increase in cell growth as measured by increased incorporation of [3H]thymidine into trichloroacetic acid-precipitable material. The growth response to EGF was concentration-dependent and the characteristics of the responses were the same using EGF from murine or human sources. With concentrations which stimulated growth, EGF was found to inhibit human thyroid cell function as measured by the release of radioimmunoassayable tri-iodothyronine into the incubation medium. Thyrotrophin (TSH) was also found to stimulate human thyroid cell growth but at concentrations far lower than those used to stimulate thyroid cell function in this system. The effect of EGF on the differentiating action of TSH on human thyroid cells in culture was also investigated; the association of thyroid cells into two-dimensional follicular structures produced by the incubation of thyroid cells at a high cell density with TSH was found to be inhibited by the addition of EGF.
J. Endocr. (1986) 108, 393–398
Search for other papers by A. G. DAVIES in
Google Scholar
PubMed
Search for other papers by I. F. DUNCAN in
Google Scholar
PubMed
Search for other papers by S. S. LYNCH in
Google Scholar
PubMed
Department of Physiology, Medical School, Birmingham, B15 2TJ and Birmingham and Midland Hospital for Women, Birmingham, BU 4HL
(Received 13 March 1975)
Because there is evidence to suggest that the level of follicle-stimulating hormone (FSH) in the hypothalamus is a factor controlling FSH secretion from the adenohypophysis (Corbin & Story, 1967; Fraschini, Motta & Martini, 1967) we have made an autoradiographic study of the hypothalamic uptake of 125I-labelled FSH in hypophysectomized adult male rats.
Human pituitary FSH was labelled with 125I by the method of Redshaw & Lynch (1974). Labelling caused a loss of less than 5% in biological potency. One microgram of the product contained 8 i.u. FSH, 0·17 i.u. luteinizing hormone and 80 μCi 125I. Human serum albumin was iodinated by the same method to the same specific activity. Six hypophysectomized albino rats each received 2 μg labelled FSH via a cannula, while labelled albumin was administered to
Search for other papers by J. S. WOODHEAD in
Google Scholar
PubMed
Search for other papers by S. JOYCE DAVIES in
Google Scholar
PubMed
Search for other papers by D. LISTER in
Google Scholar
PubMed
SUMMARY
A two-site assay has been developed for bovine PTH. This technique involves reaction of the antigen with two antibody molecules with the purpose of increasing specificity. In practice the hormone was extracted from plasma samples on to plastic tubes coated with antibody specific for PTH (1–34). Uptake was then measured using 125I-labelled antibodies specific for PTH (53–84). In this way a sensitive assay was obtained for PTH (1–84) which did not recognize molecular fragments. This technique was used in conjunction with immunoradiometric assays specific for either NH2-terminal (1–34) or CO2H-terminal (53–84) molecular fragments to study the clearance of infused PTH in the cow. Preliminary results support the hypothesis that the intact molecule is rapidly degraded in the peripheral circulation with the preferential disappearance of an NH 2-terminal fragment. Studies on endogenous secretion during calcium and EDTA infusions indicated that there was little intact hormone present at the times when CO2H-terminal immunoreactivity was readily measured.
Search for other papers by P. G. H. Byfield in
Google Scholar
PubMed
Search for other papers by S. C. Davies in
Google Scholar
PubMed
Search for other papers by S. Copping in
Google Scholar
PubMed
Search for other papers by F. E. Barclay in
Google Scholar
PubMed
Search for other papers by S. P. Borriello in
Google Scholar
PubMed
ABSTRACT
A screen of a range of bacteria normally found in gut flora identified eight with the ability to bind TSH specifically. These included the previously reported Yersinia enterocolitica, Gram-positive, Gramnegative, pathogenic and commensal organisms. Eleven preparations of TSH-receptor autoantibodies strongly able to displace 125I-labelled TSH from the mammalian TSH receptor differed in their ability to displace the tracer from binding to bacterial extracts. None could displace the tracer from E. coli 06–1, four displaced 125I-labelled TSH from E. coli V21/1 and five displaced the tracer from Y. enterocolitica. Of those immunoglobulin preparations which did react with the bacterial protein, their apparent potency compared with that of TSH in displacing tracer from bacterial binders was an order of magnitude greater than with the mammalian receptor. This is consistent with the autoantibodies having a relatively better fit with the bacterial antigen than with the receptor when compared with TSH. The bacterial-binding activity and mammalian receptor-binding activities in each of two samples co-chromatographed on a Remazol yellow GGL–Sepharose affinity column strongly indicated that the same immunoglobulin species reacts with both antigens. These results are consistent with the proposal that a bacterial protein is the primary immunogen for the TSH-receptor antibodies in at least some patients with Graves' disease.
Journal of Endocrinology (1989) 121, 571–577
Search for other papers by S. J. MAIN in
Google Scholar
PubMed
Search for other papers by R. V. DAVIES in
Google Scholar
PubMed
Search for other papers by B. P. SETCHELL in
Google Scholar
PubMed
The acute effects of a specific reduction in androgen feedback to the hypothalamus and pituitary gland have been investigated in male rats by passive immunization against testosterone. An ovine antiserum raised against testosterone which had been conjugated through position 3 to bovine serum albumin was employed.
Negative feedback control by androgens was effectively reduced by administration of the antiserum, as shown by an increase in levels of LH in the circulation. Immunized animals had a high concentration of testosterone in the circulation of which virtually all was tightly bound to antibody.
In normal animals specific increases of serum LH concentration were obtained at all ages using a low dose of antiserum. At higher doses, serum FSH concentration was also increased. The LH response was reduced by anaesthesia and sham-operation. In shamoperated rats given a high dose of antiserum for 3 days the serum concentrations of LH and FSH could not be distinguished from those which followed castration while differences were found in the pituitary contents. It was concluded that testicular androgen provides an important inhibitory feedback control of secretion of FSH as well as that of LH in the adult male rat. Some of the data can best be explained by the action of inhibin as a minor or alternative inhibitor of FSH secretion.
Search for other papers by S. J. MAIN in
Google Scholar
PubMed
Search for other papers by R. V. DAVIES in
Google Scholar
PubMed
Search for other papers by B. P. SETCHELL in
Google Scholar
PubMed
Spermatogenesis in rats was interrupted by local X-irradiation, heat or ligation of the testicular efferent ducts. A significant and specific rise in the serum level of FSH occurred 5–8 days after ligation of the efferent ducts, reaching twice the value observed in shamoperated controls by 21 days after the operation. After the testes were heated to 43 °C for 30 min, the serum levels of both LH and FSH were raised within 3 days and remained so up to 50 days after treatment. After X-irradiation, no changes in the concentration of FSH were observed in the first 21 days after treatment, but the serum levels of both gonadotrophins were increased at 49 days. By comparing the relative increases in the concentrations of FSH and LH after germ cell damage with those occurring after castration, it was evident that testicular androgens could account for only part of the normal feedback control of FSH secretion; at least one third of the inhibition of FSH secretion appeared to be due to non-androgenic sources, presumably 'inhibin'.
Search for other papers by R. K. Iles in
Google Scholar
PubMed
Search for other papers by C. L. Lee in
Google Scholar
PubMed
Search for other papers by I. Howes in
Google Scholar
PubMed
Search for other papers by S. Davies in
Google Scholar
PubMed
Search for other papers by R. Edwards in
Google Scholar
PubMed
Search for other papers by T. Chard in
Google Scholar
PubMed
ABSTRACT
Material with the immunochemical properties of the β-core of human chorionic gonadotrophin (hCG) can be found in the urine of normal postmenopausal women. However, we have been unable to detect intact hCG (using an assay which is specific for the α–β heterodimer of intact hCG) in serum of such subjects. The levels of serum LH and urinary β-core were compared in matched samples from 28 women (serum LH: median 27 U/l, range 4-70 U/l, urinary β-core: median 0·27 μg/l, range < 0·05–0·645 μg/l). Urine (4 litres) from three postmenopausal women was concentrated, dialysed and subjected to gel exclusion chromatography on Sephadex G-100. Fractions were analysed by specific assays for LH, intact hCG, total β-hCG (free β-subunit and intact hCG), free α-subunit and β-core. Material eluting at the expected position of the β-core fragment of hCG was detected in all three samples by the β-core, β-hCG and LH assays, despite the fact that the LH antibody does not recognize the authentic β-core of pregnancy. Electrophoresis and Western blotting of the concentrated urines revealed that material of the same molecular size as β-core was recognized by the antibody to LH but not by a monoclonal antibody raised to free β-hCG which also recognizes the β-core molecule of hCG. We conclude that the predominant core-like material identified in postmenopausal urine is probably derived from the β-subunit of LH.
Journal of Endocrinology (1992) 133, 459–466
Search for other papers by R. L. Kennedy in
Google Scholar
PubMed
Search for other papers by T. H. Jones in
Google Scholar
PubMed
Search for other papers by R. Davies in
Google Scholar
PubMed
Search for other papers by S. K. Justice in
Google Scholar
PubMed
Search for other papers by N. R. Lemoine in
Google Scholar
PubMed
ABSTRACT
Interleukin-6 (IL-6) has actions on a variety of endocrine tissues. The cytokine is secreted by cells of the anterior pituitary and endocrine pancreas and has recently been shown to be produced by cultures of thyroid epithelial cells. In this study we have examined some of the factors which regulate IL-6 release from an immortalized human thyroid line (HTori3).
IL-6 release over 24 h was stimulated by TSH (5000 μU/ml), by forskolin (0·01 mmol/l), by fetal calf serum (1–20%) and by epidermal growth factor (20 ng/ml). Stimulation was also apparent with γ-interferon and with tumour necrosis factor at concentrations known to enhance class II major histocompatibility antigen expression by thyroid epithelium. The most potent factor tested was interleukin-1 (IL-1), which controls IL-6 release from other cell types. Threefold stimulation was found with 1 U/ml rising to 350-fold with 1000 U/ml. The effect of IL-1 took 2 h to develop and was blocked by cycloheximide (100 μmol/l). Stimulation was not markedly inhibited by pertussis toxin. Many of the actions of IL-1 are mediated by prostaglandin E2 (PGE2). At concentrations as low as 30 nmol/l, PGE2 stimulated IL-6 release but the maximum stimulation obtained with PGE2 was only threefold. The effect of IL-1 was not inhibited by indomethacin.
These data provide further evidence that IL-6 is produced by human thyrocytes. The effect of IL-1 has not been demonstrated previously. Stimulation of IL-6 release by IL-1 did not appear to be mediated by prostaglandin. IL-6 may influence hormone release from the thyroid as it does in other tissues. High concentrations of IL-6 in the thyroid may increase infiltration by, and activation of, lymphocytes in patients with autoimmune thyroid disease.
Journal of Endocrinology (1992) 133, 477–482
Search for other papers by E. Davies in
Google Scholar
PubMed
Search for other papers by S. Rossiter in
Google Scholar
PubMed
Search for other papers by C. R. W. Edwards in
Google Scholar
PubMed
Search for other papers by B. C. Williams in
Google Scholar
PubMed
ABSTRACT
Serotoninergic control of aldosterone secretion in vivo was investigated in conscious rats with indwelling arterial cannulae. Serial blood samples were taken from the animals before and after i.p. administration of 1 ml (4 g/l) 5-hydroxytryptophan (5-HTP), the precursor of serotonin, or saline and they were analysed for 5-HTP, serotonin, 5-hydroxyindoleacetic acid, plasma renin activity (PRA), corticosterone, aldosterone, sodium and potassium concentrations. The role of the renin-angiotensin system was investigated in animals pretreated for 1 week with the angiotensin-converting enzyme inhibitor captopril (25 mg/day). 5-HTP caused a significant increase in all parameters within 45 min except for sodium and potassium. Saline administration showed no significant effect. Captopril pretreatment did not impair the increase in any parameter by 5-HTP, with the exception of the aldosterone response which was significantly attenuated, though not completely.
The results show that administration of 5-HTP, which increases serum serotonin levels, stimulates PRA, aldosterone and corticosterone secretion. Captopril pretreatment inhibits the aldosterone response, suggesting that the aldosterone stimulatory properties of 5-HTP require the presence of angiotensin II, although it is unclear whether it acts in a mediatory or permissive capacity. The failure of captopril to inhibit the aldosterone response completely suggests the involvement of other mechanisms such as the hypothalamo-pituitary adrenal axis or a direct action of serotonin on the adrenal.
Journal of Endocrinology (1991) 130, 347–355
